2025-11-12T08:45:46-06:00 2024-12-31 043379904 STOWE & DEGON LLC 95A TURNPIKE ROAD WESTBOROUGH MA 01581 990 2024-01-01 043555864 ACCELERATED CURE PROJECT INC ACCE 7814870008 800 LEXINGTON ST 21069 WALTHAM MA 024524848 SARA LOUD CEO/PRESIDENT 7814870008 2025-11-10 1 0 RICHARD ANTENUCCI P00893261 5089836700 2025-11-10 2024 2025-03-06 01:10:19Z SARA LOUD 800 LEXINGTON STREET WALTHAM MA 024524848 2884866 0 X WWW.ACCELERATEDCURE.ORG X 2001 MA THE ORGANIZATION'S MISSION IS TO ACCELERATE RESEARCH EFFORTS TO IMPROVE DIAGNOSIS, TO OPTIMIZE TREATMENT, AND TO CURE MULTIPLE SCLEROSIS. 8 8 10 70 0 0 1820285 2238138 462433 506792 51816 87584 18785 20046 2353319 2852560 0 0 0 0 867083 1164054 0 0 69040 1176907 1295974 2043990 2460028 309329 392532 3269932 3471612 523163 286632 2746769 3184980 THE ORGANIZATION'S MISSION IS TO ACCELERATE RESEARCH EFFORTS TO IMPROVE DIAGNOSIS, TO OPTIMIZE TREATMENT, AND TO CURE MULTIPLE SCLEROSIS. 0 0 2003638 SCIENTIFIC COLLABORATION AIMS TO ACCELERATE PROGRESS TOWARDS A CURE FOR MULTIPLE SCLEROSIS (MS) AND TO IMPROVE HEALTH, HEALTHCARE AND QUALITY OF LIFE FOR PEOPLE AFFECTED BY MS BY STIMULATING AND ENABLING RESEARCH, THROUGH THE PROVISION OF MUCH-NEEDED RESOURCES, AND CREATING NETWORKING OPPORTUNITIES ACROSS ALL MS STAKEHOLDERS TO SPARK NEW IDEAS AND CATALYZE UNFORESEEN CONNECTIONS. A KEY COMPONENT OF THIS PROGRAM IS THE ICONQUERMS PEOPLE-POWERED RESEARCH NETWORK IN WHICH THE INPUT AND DATA CONTRIBUTED BY NETWORK PARTICIPANTS SHAPES AND ACCELERATES RESEARCH ON TOPICS THAT MATTER MOST TO PEOPLE AFFECTED BY MS. 60339 COMMUNITY BUILDING: WE HAVE AN EXTENSIVE COMMUNITY OF PARTICIPATING MS STAKEHOLDERS CONSISTING OF PEOPLE WITH MS, THEIR FRIENDS AND FAMILIES, CLINICIANS, SCIENTISTS AND RESEARCHERS, MS-RELATED CORPORATIONS, AND OTHER INTERESTED PARTIES. EMAIL UPDATES ON THE PROGRESS OF RESEARCH, COLLABORATION, AND OTHER INFORMATION OF INTEREST ARE SENT OUT REGULARLY. PRODUCTION OF A SEASONAL NEWSLETTER IS DISTRIBUTED QUARTERLY. OUR GROUP OF VOLUNTEERS HAS FORMED A CORE COMMUNITY OF ACTIVE HELPERS. OUR CONNECTIONS TO PEOPLE AFFECTED BY MS AND OTHER MS STAKEHOLDERS ARE ESSENTIAL FOR BUILDING AND ACCELERATING RESEARCH THROUGH OUR BIOBANK/REPOSITORY AND ICONQUERMS PEOPLE-POWERED RESEARCH NETWORK. 179391 TISSUE BANK/REPOSITORY: WE HAVE RECRUITED OVER 3,000 SUBJECTS WITH AND WITHOUT MS AND OTHER DEMYELINATING DISEASES WHO HAVE DONATED BLOOD SAMPLES AND PROVIDED MEDICAL AND EPIDEMIOLOGICAL DATA THAT ARE STORED IN THE REPOSITORY AND MADE AVAILABLE TO RESEARCHERS IN EXCHANGE FOR THE DATA THEY GENERATE FROM THEIR STUDIES THAT USE THE SAMPLES. THE GOAL OF THE REPOSITORY IS TO PROVIDE RESEARCHERS WITH ACCESS TO A LARGE NUMBER OF BIOLOGICAL SAMPLES AND DATA, THAT WOULD OTHERWISE NOT BE AVAILABLE, AND TO THE AGGREGATED DATA THAT IS GENERATED FROM THE STUDIES IN ORDER THAT THEY CAN DETERMINE THE CAUSES AND MECHANISMS OF MS AND RELATED DISEASES AND THE EFFECTS OF TREATMENTS. 2243368 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 56 0 1 10 1 0 0 0 0 0 0 0 0 0 0 0 0 X 8 8 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 MA X X ED MULHERIN CO ECRATCHIT 7814870008 2B SHARP STREET HINGHAM MA 02043 LINDA KANNER DIRECTOR 1.00 X 0 0 0 MELANIE DRAYTON DIRECTOR 1.00 X 0 0 0 MICHAEL MIDDLEBROOK DIRECTOR 1.00 X 0 0 0 KRISTY DOSREIS DIRECTOR 1.00 X 0 0 0 PAMELA SAUSSY DIRECTOR 1.00 X 0 0 0 LISA BUETTNER DIRECTOR 1.00 X 0 0 0 AAKRUTI GORDE DIRECTOR 1.00 X 0 0 0 PATRICK CURLEY BOARD CHAIR 1.00 X 0 0 0 ROBERT MCBURNEY CHIEF RESEARCH OFFICER 50.00 X 97123 0 0 HOLLIE SCHMIDT VP OF SCIENTIC OPS. 50.00 X 145758 0 23992 SARA LOUD CEO/PRESIDENT 50.00 X 177984 0 0 420865 0 23992 2 0 1 0 ARIZONA STATE UNIVERSITY 660 S MILL AVE SUITE 204 TEMPE AZ 85287 SCIENTIFIC/PROGRAM CONSULTANT 118548 LIFE DATA SYSTEMS 814 WEST DIAMOND AVE STE 360 GAITHERSBUG MD 20878 SCIENTIFIC/PROGRAM CONSULTANT 116288 2 730087 1508051 19197 2238138 PROGRAM FEES 900099 506792 506792 506792 87038 87038 24734 24188 546 546 546 28164 8118 20046 20046 2852560 506792 0 107630 444857 430618 3560 10679 537625 525891 208 11526 19997 19482 71 444 83559 77213 1836 4510 78016 76017 352 1647 72887 72887 127130 94713 31589 828 21688 6443 12098 3147 14724 12700 1831 193 26031 25895 128 8 50764 34947 15817 SCIENTIFIC PROGRAM CONS 540057 540057 RESEARCH AND DATA COLLE 331461 331461 OTHER PROGRAM EXPENSES 111232 67931 7243 36058 2460028 2243368 147620 69040 297154 110944 2103123 1710348 537682 1185031 155467 297248 18162 39331 248725 120015 150900 128710 4937 0 2507 0 3269932 3471612 523163 286632 523163 286632 X 2102672 2336461 644097 848519 2746769 3184980 3269932 3471612 392532 55 45624 0 X 0 1 X 1 0 X 1560357 1232135 1532531 1820285 2238138 8383446 232532 496973 724881 462433 506792 2423611 1792889 1729108 2257412 2282718 2744930 10807057 79946 25000 6410 6815 19455 137626 0 79946 25000 6410 6815 19455 137626 10669431 128 609 18 52686 87038 140479 128 609 18 52686 87038 140479 1793017 1729717 2257430 2335404 2831968 10947536 0.97460 0.97480 0.01280 0.00560 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 248725 120015 128710 128710 X 2864368 55 11753 11808 2852560 0 2852560 2471781 11753 11753 2460028 0 2460028 PART X, LINE 2: THE ORGANIZATION HAS DETERMINED THAT THERE ARE NO MATERIAL UNCERTAIN TAX POSITIONS THAT REQUIRE RECOGNITION OR DISCLOSURE IN THE FINANCIAL STATEMENTS. PART X, LINE 2: TAX YEAR FROM 2021 THROUGH THE CURRENT YEAR REMAIN OPEN FOR EXAMINATION BY FEDERAL AND STATE TAX AUTHORITIES. SPECIAL EVENTS 28164 28164 8118 28164 28164 8118 8118 20046 X 0 0 0 0 0 0 0 0 0 SARA LOUD CEO/PRESIDENT 177984 0 0 0 0 0 0 0 0 0 177984 0 0 0 HOLLIE SCHMIDT VP OF SCIENTIC OPS. 145758 0 0 0 0 0 0 0 23992 0 169750 0 0 0 FORM 990, PART VI, SECTION B, LINE 11B MANAGEMENT REVIEWS THE DRAFT FORM 990 FOR ACCURACY. THE ORGANIZATION'S ACCOUNTING VENDOR REVIEWS THE DRAFT FORM 990 FOR ACCURACY. FOLLOWING RESOLUTION OF ANY QUESTIONS OR CHANGES FROM INITIAL REVIEW, THE 990 IS EMAILED TO THE GOVERNING BODY FOR REVIEW PRIOR AN APPROVAL. IF THERE ARE ANY QUESTIONS OR REQUESTED CHANGES, THEY ARE ADDRESSED BEFORE THE 990 IS FILED. FORM 990, PART VI, SECTION B, LINE 12C THE CONFLICT OF INTEREST COVERS ALL EMPLOYEES AND BOARD MEMBERS. THE CONFLICT OF INTEREST POLICY AND DISCLOSURE STATEMENT IS REVIEWED AND SIGNED ANNUALLY BY COVERED INDIVIDUALS. ADDITIONALLY, THE POLICY AND STATEMENT IS REVIEWED UPON EXECUTION OF ANY EXTERNAL AGREEMENTS REQUIRING AFFIRMATION OF A POLICY AND DISCLOSURE. POTENTIAL CONFLICTS THAT ARISE ARE ADDRESSED IMMEDIATELY. THE CEO IS RESPONSIBLE FOR MONITORING COMPLIANCE WITH THE POLICY. FORM 990, PART VI, SECTION B, LINE 15 THE CEO'S COMPENSATION IS DETERMINED BY THE COMPENSATION COMMITTEE AND APPROVED BY THE BOARD ON AN ANNUAL BASIS. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S FINANCIAL STATEMENTS ARE ON THEIR WEBSITE. ITS GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON REQUEST.